Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-14

FDA Approved: NITROFURANTOIN — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved an original application for nitrofurantoin from Somerset Therapeutics, LLC. The product is intended for treatment of urinary tract infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrofurantoin (Nitrofurantoin)

Snippet

ORIG AP for NITROFURANTOIN (NITROFURANTOIN)